Saturday, January 28, 2023
Home Tags Aurobindo Pharma

Tag: Aurobindo Pharma

USFDA issues Form 483 with 10 observations to Aurobindo Pharma

Aurobindo Pharma announced that the United States Food and Drug Administration (USFDA) has issued Form 483 with 10 observations after the inspection...

USFDA gives EIR to Aurobindo Pharma for its AP facility

New Delhi: Aurobindo Pharma Ltd. said it has received an Establishment Inspection Report (EIR) from the US health regulator for its manufacturing facility at Pydibhimavaram in...

Drug recall: These drugs recalled by Aurobindo for this reason

Aurobindo Pharma units are recalling different products in the US market for manufacturing lapses, as per the US health regulator.

Drug recall: These products recalled by Dr Reddy’s, Cipla, and Aurobindo

Drugs recall Leading drug firms like Dr. Reddy's Laboratories, Cipla, and Aurobindo Pharma are recalling different products in the US market for...

USFDA issues Form 483 for 3 observations to Aurobindo Pharma

Aurobindo Pharma said the US health regulator has issued Form 483 with three observations after inspecting its manufacturing facility at Pydibhimavaram in...

USFDA gives nod for Triamcinolone Acetonide injectable suspension

New Delhi: Aurobindo Pharma Ltd on Wednesday said its arm, Eugia Pharma Specialities Ltd, has received final approval from the US health regulator to manufacture and...

USFDA completes inspection of Aurobindo Pharma with no remaining deficiencies

The pre-approval inspection of Aurobindo Pharma was carried out from 8 February 2022 to 15 February 2022. On completion of the inspection,...

USFDA gives nod to these companies for Bortezomib for injection

Zudus Zydus Lifesciences has received final approval from the US Food and Drug Administration (USFDA) to market Bortezomib...

USFDA issues warning letter to Aurobindo Pharma for manufacturing lapses...

New Delhi: The US Food and Drug Administration (USFDA) has issued a warning letter to Aurobindo Pharma for violating current good manufacturing practice norms...

USFDA gives warning letter to Aurobindo Pharma for API facility

Aurobindo Pharma yesterday said it has received a warning letter from the US health regulator for its Hyderabad-based Unit I, an Active...

Aurobindo Pharma, MSN Labs seek DCGI nod for Phase-III trials of...

Two Indian pharmaceutical companies have sought permission from India’s drug regulator to continue phase III trials on antiviral drug molnupiravir in mild C-19 patient....

Drug recall: Glenmark, Aurobindo recall multiple products

Glenmark Pharmaceuticals and Aurobindo Pharma are recalling multiple products in the US market due to various reasons like deviation from standard manufacturing protocols and presence of foreign...

Aurobindo Pharma gets Indian patent for this Antiviral Drug

The Indian Patent Office has granted patent to Aurobindo Pharma for its process for the preparation of its antiviral drug valacyclovir, which...

Aurobindo Pharma gets USFDA nod for cancer treatment drug

New Delhi: Drug firm Aurobindo Pharma on Friday said its arm Eugia Pharma Specialities has received approval from the US health regulator for Cyclophosphamide injection, used in...

PLI Scheme: Govt re-invites applications to Mfr Erythromycin

The Department of Pharmaceuticals (DoP) has re-invited applications from eligible applicants to manufacture fermentation based key starting material/drug intermediate erythromycin thiocyanate under...

Pharma Companies recall these drugs in US

Sun Pharma, Dr Reddy’s Laboratories, Aurobindo Pharma and Jubilant Pharma are recalling products in the US market for various reasons.

Aurobindo Pharma gets USFDA nod for generic Droxidopa capsules

New Delhi: Drug major Aurobindo Pharma on Friday said it has received final approval from the US health regulator to manufacture and market Droxidopa capsules, used...

More Pharma firms for PLI scheme to boost bulk drug output:...

The government plans to select more pharmaceutical firms for its production-linked incentive (PLI) scheme for 37 bulk drugs by the end of...

Aurobindo Pharma to mfr COVAXX vaccine for India and UNICEF

Aurobindo Pharma Ltd said on Thursday that it will make COVAXX's C-19 vaccine candidate for India and UNICEF under a licensing deal....

Pfizer moves US court against Aurobindo, Dr Reddy’s on cancer drug

HYDERABAD: Pfizer Inc and its group companies filed a petition in a US court against Aurobindo Pharma Ltd and Dr Reddy's Laboratories alleging that the Indian drug...

Indian Pharma Cos recall various products in US market

New Delhi: Indian drug firms like Marksans Pharma, Aurobindo Pharma, Zydus and Jubilant are recalling products in the US market, as per the latest enforcement report by the...

Aurobindo Pharma gets USFDA nod for pain treatment injection

New Delhi: Drug firm Aurobindo Pharma on Thursday said it has received final approval from the US health regulator for its generic Acetaminophen injection, used...

Aurobindo Pharma acquires 100 % share of Eugia Pharma Specialities

Aurobindo Pharma has entered into a share purchase agreement today to acquire 100 per cent equity share capital of MViyeS Pharma Ventures....

USFDA issues 9 observations to Aurobindo Pharma

Hyderabad: The US Food and Drug Administration (FDA) has issued a 'Form 483' with nine observations to a manufacturing facility in the...

Latest posts

Govt Job: For M.Pharm, MS Pharm, M.Tech in DPSRU

Delhi Pharmaceutical Sciences and Research University (DPSRU) is the first Pharmacy University in India and third in the world, established by Act...

Authors

76 POSTS0 COMMENTS
40 POSTS0 COMMENTS
32 POSTS0 COMMENTS
15 POSTS0 COMMENTS
13 POSTS0 COMMENTS
11 POSTS0 COMMENTS
7 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS